Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154972 | SCV000204654 | uncertain significance | not specified | 2014-05-01 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The Glu6964Lys vari ant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 2/3868 African American chromosomes by the NHLBI Exom e Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs190192954). Com putational prediction tools and conservation analysis do not provide strong supp ort for or against an impact to the protein, though 1 mammal (bush-tailed rat) c arries a lysine (Lys) at this position raising the possibility that this change may be tolerated. In summary, the clinical significance of the Glu6964Lys varian t is uncertain. |
Labcorp Genetics |
RCV000531149 | SCV000642856 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704126 | SCV000714766 | likely benign | not provided | 2020-11-10 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001704126 | SCV003827317 | uncertain significance | not provided | 2020-10-24 | criteria provided, single submitter | clinical testing |